Literature DB >> 16239348

A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes.

Annick Le Dur1, Vincent Béringue, Olivier Andréoletti, Fabienne Reine, Thanh Lan Laï, Thierry Baron, Bjørn Bratberg, Jean-Luc Vilotte, Pierre Sarradin, Sylvie L Benestad, Hubert Laude.   

Abstract

Scrapie in small ruminants belongs to transmissible spongiform encephalopathies (TSEs), or prion diseases, a family of fatal neurodegenerative disorders that affect humans and animals and can transmit within and between species by ingestion or inoculation. Conversion of the host-encoded prion protein (PrP), normal cellular PrP (PrP(c)), into a misfolded form, abnormal PrP (PrP(Sc)), plays a key role in TSE transmission and pathogenesis. The intensified surveillance of scrapie in the European Union, together with the improvement of PrP(Sc) detection techniques, has led to the discovery of a growing number of so-called atypical scrapie cases. These include clinical Nor98 cases first identified in Norwegian sheep on the basis of unusual pathological and PrP(Sc) molecular features and "cases" that produced discordant responses in the rapid tests currently applied to the large-scale random screening of slaughtered or fallen animals. Worryingly, a substantial proportion of such cases involved sheep with PrP genotypes known until now to confer natural resistance to conventional scrapie. Here we report that both Nor98 and discordant cases, including three sheep homozygous for the resistant PrP(ARR) allele (A(136)R(154)R(171)), efficiently transmitted the disease to transgenic mice expressing ovine PrP, and that they shared unique biological and biochemical features upon propagation in mice. These observations support the view that a truly infectious TSE agent, unrecognized until recently, infects sheep and goat flocks and may have important implications in terms of scrapie control and public health.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239348      PMCID: PMC1276041          DOI: 10.1073/pnas.0502296102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Prion diseases: BSE in sheep bred for resistance to infection.

Authors:  Fiona Houston; Wilfred Goldmann; Angela Chong; Martin Jeffrey; Lorenzo González; James Foster; David Parnham; Nora Hunter
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

2.  Assessing the efficacy of a ram-genotyping programme to reduce susceptibility to scrapie in Great Britain.

Authors:  M Arnold; C Meek; C R Webb; L J Hoinville
Journal:  Prev Vet Med       Date:  2002-12-30       Impact factor: 2.670

Review 3.  The epidemiology of scrapie.

Authors:  L A Detwiler; M Baylis
Journal:  Rev Sci Tech       Date:  2003-04       Impact factor: 1.181

4.  Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages.

Authors:  Richard Race; Kimberly Meade-White; Anne Raines; Gregory J Raymond; Byron Caughey; Bruce Chesebro
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

Review 5.  New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives.

Authors:  Hubert Laude; Didier Vilette; Annick Le Dur; Fabienne Archer; Solange Soulier; Nathalie Besnard; Rachid Essalmani; Jean-Luc Vilotte
Journal:  C R Biol       Date:  2002-01       Impact factor: 1.583

6.  Molecular classification of sporadic Creutzfeldt-Jakob disease.

Authors:  Andrew F Hill; Susan Joiner; Jonathan D F Wadsworth; Katie C L Sidle; Jeanne E Bell; Herbert Budka; James W Ironside; John Collinge
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

7.  Phenotyping of protein-prion (PrPsc)-accumulating cells in lymphoid and neural tissues of naturally scrapie-affected sheep by double-labeling immunohistochemistry.

Authors:  Olivier Andréoletti; Patricia Berthon; Etienne Levavasseur; Daniel Marc; Frédéric Lantier; Eoin Monks; Jean-Michel Elsen; François Schelcher
Journal:  J Histochem Cytochem       Date:  2002-10       Impact factor: 2.479

8.  Regional heterogeneity of cellular prion protein isoforms in the mouse brain.

Authors:  Vincent Beringue; Gary Mallinson; Maria Kaisar; Mourad Tayebi; Zahid Sattar; Graham Jackson; David Anstee; John Collinge; Simon Hawke
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

Review 9.  Prion diseases: what is the neurotoxic molecule?

Authors:  R Chiesa; D A Harris
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

10.  BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Melanie Desbruslais; Susan Joiner; Ian Gowland; Andrew L Wood; Julie Welch; Andrew F Hill; Sarah E Lloyd; Jonathan D F Wadsworth; John Collinge
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

View more
  97 in total

1.  Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.

Authors:  Caroline Lacroux; Didier Vilette; Natalia Fernández-Borges; Claire Litaise; Séverine Lugan; Nathalie Morel; Fabien Corbière; Stéphanie Simon; Hugh Simmons; Pierrette Costes; Jean-Louis Weisbecker; Isabelle Lantier; Frederic Lantier; François Schelcher; Jacques Grassi; Joaquin Castilla; Olivier Andréoletti
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  The importance of the PrP genotype in active surveillance for ovine scrapie.

Authors:  S C Tongue; J W Wilesmith; J Nash; M Kossaibati; J Ryan
Journal:  Epidemiol Infect       Date:  2007-06-25       Impact factor: 2.451

3.  PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Authors:  Sophie Paquet; Nathalie Daude; Marie-Pierre Courageot; Jérôme Chapuis; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

4.  Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments.

Authors:  Jonathan P Owen; Helen C Rees; Ben C Maddison; Linda A Terry; Leigh Thorne; Roy Jackman; Garry C Whitelam; Kevin C Gough
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

5.  The oral secretion of infectious scrapie prions occurs in preclinical sheep with a range of PRNP genotypes.

Authors:  Kevin C Gough; Claire A Baker; Helen C Rees; Linda A Terry; John Spiropoulos; Leigh Thorne; Ben C Maddison
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  PrP genotype frequencies of Quebec sheep breeds determined by real-time PCR and molecular beacons.

Authors:  Yvan L'Homme; Anne Leboeuf; Johanne Cameron
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

Review 7.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

8.  Similar biochemical signatures and prion protein genotypes in atypical scrapie and Nor98 cases, France and Norway.

Authors:  Jean-Noël Arsac; Olivier Andreoletti; Jean-Marc Bilheude; Caroline Lacroux; Sylvie L Benestad; Thierry Baron
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Atypical scrapie in sheep from a UK research flock which is free from classical scrapie.

Authors:  Hugh A Simmons; Marion M Simmons; Yvonne I Spencer; Melanie J Chaplin; Gill Povey; Andrew Davis; Angel Ortiz-Pelaez; Nora Hunter; Danny Matthews; Anthony E Wrathall
Journal:  BMC Vet Res       Date:  2009-02-10       Impact factor: 2.741

10.  Transmissibility of atypical scrapie in ovine transgenic mice: major effects of host prion protein expression and donor prion genotype.

Authors:  Jean-Noël Arsac; Dominique Bétemps; Eric Morignat; Cécile Féraudet; Anna Bencsik; Denise Aubert; Jacques Grassi; Thierry Baron
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.